ELI LILLY & Co — Director's Dealing 2024

Nov 1, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-10-31

Reporting Person: Van Naarden Jacob (EVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-10-31	Common Stock	G	4302	—	Disposed	11845	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4342	Indirect
Common Stock	4302	Indirect

Footnotes

F1: The reporting person transferred 4,302 shares of Eli Lilly and Company common stock to the reporting person's spouse.

F2: The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.